In vitro studies revealed that cell migration and invasion are inhibited in breast cancer cells null for the oncogene lysine‐specific demethylase 2A (KDM2A), via TET2‐mediated activation of the downstream tumor suppressors E‐cadherin and epithelial cell adhesion molecule (EpCAM) [99]. Here, TET2 is linked to breast cancer.